BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 38097778)

  • 1. Same yet different - how lymph node heterogeneity affects immune responses.
    Cruz de Casas P; Knöpper K; Dey Sarkar R; Kastenmüller W
    Nat Rev Immunol; 2024 May; 24(5):358-374. PubMed ID: 38097778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy.
    Thomas SN; Rohner NA; Edwards EE
    Annu Rev Biomed Eng; 2016 Jul; 18():207-33. PubMed ID: 26928210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance.
    Andorko JI; Hess KL; Jewell CM
    AAPS J; 2015 Mar; 17(2):323-38. PubMed ID: 25533221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Strategies for Lymph Node Targeted Immune Activation.
    Chen Y; De Koker S; De Geest BG
    Acc Chem Res; 2020 Oct; 53(10):2055-2067. PubMed ID: 32910636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lymph node neutrophil.
    Hampton HR; Chtanova T
    Semin Immunol; 2016 Apr; 28(2):129-36. PubMed ID: 27025975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph nodes and human tumors (review).
    Lores B; García-Estevez JM; Arias C
    Int J Mol Med; 1998 Apr; 1(4):729-33. PubMed ID: 9852289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartmentalized multicellular crosstalk in lymph nodes coordinates the generation of potent cellular and humoral immune responses.
    Poirot J; Medvedovic J; Trichot C; Soumelis V
    Eur J Immunol; 2021 Dec; 51(12):3146-3160. PubMed ID: 34606627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity.
    Swartz MA; Lund AW
    Nat Rev Cancer; 2012 Feb; 12(3):210-9. PubMed ID: 22362216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph Nodes: The Unrecognized Barrier against Pathogens.
    Bogoslowski A; Kubes P
    ACS Infect Dis; 2018 Aug; 4(8):1158-1161. PubMed ID: 29856591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lymph node revisited: development, morphology, functioning, and role in triggering primary immune responses.
    Sainte-Marie G
    Anat Rec (Hoboken); 2010 Feb; 293(2):320-37. PubMed ID: 20101739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of Protein Therapeutics: A Lymph Node Perspective.
    Fu K; March K; Alexaki A; Fabozzi G; Moysi E; Petrovas C
    Front Immunol; 2020; 11():791. PubMed ID: 32477334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular tracking devices quantify antigen distribution and archiving in the murine lymph node.
    Walsh SM; Sheridan RM; Lucas ED; Doan TA; Ware BC; Schafer J; Fu R; Burchill MA; Hesselberth JR; Tamburini BAJ
    Elife; 2021 Apr; 10():. PubMed ID: 33843587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-draining lymph nodes: At the crossroads of metastasis and immunity.
    du Bois H; Heim TA; Lund AW
    Sci Immunol; 2021 Sep; 6(63):eabg3551. PubMed ID: 34516744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Let it be: Preserving tumor-draining lymph nodes in the era of immuno-oncology.
    Saddawi-Konefka R; Schokrpur S; Gutkind JS
    Cancer Cell; 2024 Jun; 42(6):930-933. PubMed ID: 38861928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node targeting strategies to improve vaccination efficacy.
    Jiang H; Wang Q; Sun X
    J Control Release; 2017 Dec; 267():47-56. PubMed ID: 28818619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A surface charge dependent enhanced Th1 antigen-specific immune response in lymph nodes by transfersome-based nanovaccine-loaded dissolving microneedle-assisted transdermal immunization.
    Wu X; Li Y; Chen X; Zhou Z; Pang J; Luo X; Kong M
    J Mater Chem B; 2019 Aug; 7(31):4854-4866. PubMed ID: 31389952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlocking the therapeutic potential of primary tumor-draining lymph nodes.
    Rotman J; Koster BD; Jordanova ES; Heeren AM; de Gruijl TD
    Cancer Immunol Immunother; 2019 Oct; 68(10):1681-1688. PubMed ID: 30944963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil recruitment to lymph nodes limits local humoral response to Staphylococcus aureus.
    Kamenyeva O; Boularan C; Kabat J; Cheung GY; Cicala C; Yeh AJ; Chan JL; Periasamy S; Otto M; Kehrl JH
    PLoS Pathog; 2015 Apr; 11(4):e1004827. PubMed ID: 25884622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapy.
    Zheng R; Kjaergaard J; Lee WT; Cohen PA; Shu S
    Cancer Treat Res; 2007; 135():223-37. PubMed ID: 17953420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.